Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	48.75	-30.57	-59.66
Graham Fair Price	41.54	3.46	2.44
PEG	153.53	< 0.005	< 0.005
Price/Book	-16.74	0.19	0.23
Price/Cash Flow	94.78	-1.65	-31.70
Prices/Earnings	58.37	-0.22	-0.53
Price/Sales	-58.37	0.23	0.56
Price/FCF	94.78	-1.65	-31.70
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	528.65	0.09	0.01
Operating Margin	3.75	-0.16	-0.17
ROA	-100.00	-0.02	-0.01
ROE	-0.11	-0.21	-100.00
ROIC	-0.02	-0.03	-98.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.09	-99.83
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.30	-0.93	28.69
EPS QOQ	-6.09	-1.00	83.58
FCF QOQ	-1.07	-14.97	-1297.44
Revenue QOQ	-0.74	1.00	34.58
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1430.25	771.85	-46.03
Days Sales Outstanding (DSO)	15.92	174.82	998.31
Inventory Turnover	0.06	0.12	85.30
Debt/Capitalization	0.82	0.82	< 0.005
Quick Ratio	0.13	0.39	202.25
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.58	1.58	0.08
Cash	1.06	1.05	-0.57
Capex	< 0.005	-0.01	-100.17
Free Cash Flow	-0.01	-0.18	-1497.93
Revenue	0.64	1.28	100.17
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.53	1.53	-0.47
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-56.25	-29.10	48.27
Naive Interpretation	Member

06 - Financial Health · Weak

Rating